178813-77-9

Basic information

• Product Name: 2,6-DICHLORO-3-FLUOROBENZALDEHYDE
• Synonyms: 2,6-DICHLORO-3-FLUOROBENZALDEHYDE
• CAS NO: 178813-77-9
• Molecular Formula: C7H3Cl2FO
• Molecular Weight: 193.0025232
• Mol File: 178813-77-9.mol
• Article Data: 10

Chemical Properties

• Melting Point: 63-65℃
• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 2,6-DICHLORO-3-FLUOROBENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-DICHLORO-3-FLUOROBENZALDEHYDE(178813-77-9)
• EPA Substance Registry System: 2,6-DICHLORO-3-FLUOROBENZALDEHYDE(178813-77-9)

Safety Data

• Hazardous Substances Data: 178813-77-9(Hazardous Substances Data)

Usage

General Description

2,6-Dichloro-3-fluorobenzaldehyde is a chemical compound with the molecular formula C7H3Cl2FO. It is a white to off-white solid that is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. 2,6-Dichloro-3-fluorobenzaldehyde is known for its strong smell and is considered to be harmful if inhaled or swallowed. It is primarily used in research and development activities and is not widely used in commercial products. 2,6-Dichloro-3-fluorobenzaldehyde is usually handled and stored in a controlled environment to prevent any potential harm to human health or the environment.

Upstream product

• 68-12-2 N,N-dimethyl-formamide 
• 290835-85-7 2',6'-dichloro-3'-fluoroacetophenone 
• 178813-78-0 2,6?dichloro?3?fluorobenzoic acid 
• 1227611-90-6 (2,6-dichloro-3-fluorophenyl)methanol 
• 107-31-3 Methyl formate 
• 1435-48-9 1,3-dichloro-4-fluorobenzene 
• 98-87-3 benzylidene dichloride 
• 178813-79-1 2,6-dichloro-3-fluorobenzal chloride 

Downstream Products

• 1227611-86-0 ((S)-1-{5-bromo-3-[(S)-1-(2,6-dichloro-3-fluorophenyl)ethyl]pyrrolo[2,3-b]pyridine-1-carbonyl}-3-methylbutyl)carbamic acid 9H-fluoren-9-ylmethyl ester 
• 1227611-87-1 ((S)-1-{5-bromo-3-[(R)-1-(2,6-dichloro-3-fluorophenyl)ethyl]pyrrolo[2,3-b]pyridine-1-carbonyl}-3-methylbutyl)carbamic acid 9H-fluoren-9-ylmethyl ester 
• 1227611-46-2 3-(4-{3-[1-(2,6-dichloro-3-fluorophenyl)ethyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-pyrazol-1-yl)-azetidine-1-carboxamide 
• 1227611-70-2 3-[(R)-1-(2,6-dichloro-3-fluorophenyl)ethyl]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine 
• 1227611-78-0 4-(4-{3-[1-(2,6-dichloro-3-fluorophenyl)ethyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-pyrazol-1-yl)cyclohexanone 
• 1227611-38-2 2-amino-1-(4-{3-[1-(2,6-dichloro-3-fluorophenyl)ethyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-3,6-dihydro-2H-pyridin-1-yl)-2-methylpropan-1-one 
• 1227611-57-5 5-{3-[(S)-1-(2,6-dichloro-3-fluorophenyl)ethyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-3,6-dihydro-2H-pyridine-1-carboxamide 
• 1227611-39-3 4-{3-[1-(2,6-dichloro-3-fluorophenyl)ethyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-3,6-dihydro-2H-pyridine-1-sulfonic acid amide 
• 1227611-26-8 4-{3-[1-(2,6-dichloro-3-fluorophenyl)ethyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-3,6-dihydro-2H-pyridine-1-carboxamide 
• 1227611-45-1 3-(4-{3-[1-(2,6-dichloro-3-fluorophenyl)ethyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-pyrazol-1-yl)-azetidine-1-carbaldehyde 
• 1227611-44-0 5-(1-azetidin-3-yl-1H-pyrazol-4-yl)-3-[1-(2,6-dichloro-3-fluoro-phenyl)ethyl]-1H-pyrrolo[2,3-b]pyridine 
• 1227611-56-4 3-[(S)-1-(2,6-dichloro-3-fluorophenyl)ethyl]-5-(1,2,5,6-tetrahydropyridin-3-yl)-1H-pyrrolo[2,3-b]pyridine 
• 1227611-31-5 4-{3-[1-(2,6-dichloro-3-fluorophenyl)ethyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-3,6-dihydro-2H-pyridine-1-carbaldehyde 
• 1227611-25-7 3-[1-(2,6-dichloro-3-fluorophenyl)-ethyl]-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-pyrrolo[2,3-b]pyridine 

Relevant articles and documents

PIEZO1 AGONISTS FOR THE PROMOTION OF BONE FORMATION

Disclosed herein are Piezo 1 agonists. Also disclosed herein are methods of stimulating tissue anabolism in a subject comprising administering an effective amount of a Piezo 1 agonist and methods for chemically mimicking mechanical stimulation of a cell expressing Piezo 1 comprising contacting a cell expressing Piezo1 with an effective amount of a Piezo 1 agonist.

Method of fluorination using iodonium ylides

A process for fluorination of aromatic compounds employing iodonium ylides and applicable to radiofluorination using 18F is described. Processes, intermediates, reagents and radiolabelled compounds are described.

FUSED BICYCLIC KINASE INHIBITORS

Compounds of Formula (I), pharmaceutically acceptable salts thereof, synthesis, intermediates, formulations, and methods of disease treatment therewith, including treatment of cancers, such as tumors driven at least in part by at least one of MET, RON, ALK, IR, or IGF-1R. This Abstract is not limiting of the invention.